Alnylam drug approval marks watershed moment for gene-silencing field By: Boston Business Journal via Business Journals August 13, 2018 at 22:20 PM EDT Alnylam is one of several local biotechs developing drugs based on Nobel Prize-winning technology known as RNA interference. Read More >>